Healthcare
Wednesday, January 4, 2017
BRIEF-Ironwood announces new drug application for DUZALLO has been accepted for FDA review
* Ironwood announces new drug application for duzallo(tm)
(fixed-dose combination of lesinurad and allopurinol) has been
accepted for fda review
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment